Lucienne Marie Ide, M.D., PH.D., is the Founder and Chief Executive Officer of Rimidi, a digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software, services, and connected devices. She brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi’s strategy and vision. Motivated by the belief that we can do so much better as individuals, in industry and society, Lucie left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.
Now more than ever, enhancing primary care practices to include CGM capabilities is a crucial goal requiring the support and involvement of the broader healthcare community.
Adding CDS Hooks — the HL7 published specification for clinical decision support — to the technology mix will streamline clinical workflows, particularly as the sources and quantities of data continue to expand at a rapid pace.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Rather than relying on a third-party view from a doctor or nurse, patient-reported outcomes provide a real-world assessment of healthcare’s effectiveness from those experiencing it firsthand.
Every patient who could benefit should be armed with the sophisticated and validated technologies currently available to monitor key biometrics at home to alert patients and their clinicians of abnormalities and opportunities for early intervention.